Form D · Pharmaceuticals

Silvergate Pharmaceuticals, Inc.

Greenwood Village, CO · CIK 0001520642

Offering snapshot reported Oct 18, 2016 · SEC filing

Reported sold
$4.6M
Offering amount: $4.6M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 3, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 18, 2016Initial$4,600,000No comparison10SEC filing
Oct 14, 2015Initial$1,600,000No comparison9SEC filing
Sep 12, 2014Initial$1,000,000No comparison7SEC filing
Jun 14, 2013Amendment$23,554,167$20,539,167vs May 17, 201113SEC filing
May 17, 2011Initial$3,015,000No comparison2SEC filing

Offering details

Securities
Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-272793
Conversion of Convertible Promissory Notes and Warrants to Preferred Stock

Source: Form D, filed Oct 18, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Barry Barnard Executive
Michael Beckloff Executive
Bhaskar Chaudhuri Director
Bhaskar Chauduri Director
Bhaskar Chaundhuri Director
Nathan Every Director
Patrick Heron Director
Robert Mauro Executive
Laura Medina Executive
Mark Parrish Director
Frank Segrave Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
6251 Greenwood Plaza Boulevard Suite 101
Greenwood Village, CO, 80111